The mechanism: On April 6, 2026, a presidential proclamation restructured Section 232 tariffs on aluminum, steel, and copper so the duty applies to the full customs value of covered articles and derivatives — not just the metal content — and June 2026 amendments expanded product coverage further. Aerospace largely dodged direct finished-aircraft tariffs through "zero-for-zero" civil aviation carve-outs with the EU, UK, and Japan. But the raw billet, plate, and forging stock that becomes engine disks, landing gear, and structural castings still gets hit walking through the door. That cost has to land somewhere in the supply chain — and the market is pricing it as a Boeing problem when it's actually a subcontractor problem.
Markets
Boeing's Tariff Immunity Is Real — It's the Suppliers Beneath It Who Pay
Section 232 tariffs on aluminum, steel, and derivatives are climbing again in 2026 — but Boeing's fixed-price supplier contracts push the cost downstream, leaving Howmet, TransDigm, and Heico to price it forward while unnamed sub-tier forgers eat the margin hit.
Boeing's contract terms were built for exactly this: push the commodity risk downstream and let the forgers underneath absorb it.
Who cashes in:
Howmet Aerospace HWM looks exposed at first glance — it melts and forges the titanium, aluminum, and nickel-superalloy inputs tariffs target directly. But Howmet's own risk disclosures say the company "expects to pass along the costs associated with tariffs to customers... in the form of a cost pass-through mechanism." With ~68% of revenue from aerospace and near-monopoly positions in structural castings and fasteners for the 737 and 787, Howmet has the pricing leverage to bill the tariff forward rather than eat it.
TransDigm TDG sells parts where it's the sole FAA-approved source — roughly 80% of revenue from monopoly product lines. Sole-source status means metals-cost inflation flows straight into list price with no customer alternative to switch to.
Heico HEI occupies the same seat from the other side: its PMA aftermarket parts business reverse-engineers OEM components and still prices below Boeing/GE originals even after input costs rise, because its margin structure starts from a lower cost base.
GE Aerospace (GE) engine sales run on long-term, escalation-adjusted contracts and spare-parts aftermarket economics that already assume input volatility gets repriced into service agreements.
Who is exposed:
Boeing BA itself is largely a pass-through node — its supplier terms (the standard "GP" fixed-price provisions) push commodity-index risk downstream, and delivery volumes matter more to BA's stock than a few points of forging-cost inflation. The real exposure sits one and two tiers down: smaller, non-proprietary forgers and machine shops without Howmet's scale or TransDigm's sole-source pricing power. They sign fixed-price purchase orders to Boeing and GE with no tariff-escalation clause, and absorb the metals spike directly in gross margin. That squeeze doesn't show up in a ticker — it shows up in shop closures and consolidation, which ultimately feeds Howmet's and TransDigm's roll-up acquisition pipeline.
Delta DAL and United UAL are exposed only secondhand: any tariff-driven rise in Boeing's build cost eventually shows up in aircraft order pricing and lease rates, a slow-moving cost that airlines negotiate around, not absorb overnight.
The play: Don't short Boeing on the tariff headline — its contract architecture was built for exactly this. Watch Howmet's gross margin and TransDigm's price/volume mix in coming quarters as the tell: if margins hold or expand while sub-tier forgers report compression, that's the tariff wash confirmed in the numbers.
Source: original report ↗
Free alerts
Free: catalyst alerts, straight to your inbox.
Get the White House orders, federal contracts, and FDA decisions that move money — with who cashes in — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Money Racket Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $40/moJoin the owners who run ahead of the industry. Cancel anytime, one click.